Psoriatic Arthritis Latest Advances
Find the Latest Research About Psoriatic Arthritis
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13157 publications
Impact of Nonmedical Adalimumab Switches in a Rheumatology Patient Population.
Journal: The Journal of pharmacy technology : jPT : official publication of the Association of Pharmacy Technicians
Published: September 02, 2026
Waist circumference provides improved cardiometabolic discrimination compared with body mass index in psoriatic disease: discrimination and reclassification analyses.
Journal: Postgraduate medicine
Published: August 30, 2026
DIFFERENTIAL DIAGNOSIS OF HAND ARTHRITIS ON RADIOGRAPHS USING DEEP LEARNING.
Journal: Osteoarthritis imaging
Published: August 20, 2026
Cardiovascular and Thromboembolic Risk With Upadacitinib in Spondyloarthritis and Inflammatory Bowel Disease: A Meta-Analysis of Randomized Controlled Trials.
Journal: Journal of cardiovascular pharmacology
Published: August 19, 2026
Efficacy and safety of golimumab biosimilar BAT2506 in patients with active psoriatic arthritis after switching from reference golimumab: 52-week results of a phase 3, double-blind, randomized study.
Journal: Expert opinion on biological therapy
Published: August 19, 2026
Early life exposures association with later diagnosis of spondyloarthritis: A population-based case-control study.
Journal: The Journal of rheumatology
Published: August 15, 2026
Employers' perspectives on vocational rehabilitation for people with inflammatory arthritis: a qualitative study.
Journal: Disability and rehabilitation
Published: August 11, 2026
IL-17 at the eye-joint interface in psoriatic disease: mechanisms, clinical correlates, and therapeutic implications.
Journal: Expert review of clinical immunology
Published: August 10, 2026
Cross-disease immunological comparison reveals shared systemic immune activation across the broader spondyloarthritis spectrum.
Journal: Immunological medicine
Published: August 08, 2026
Findings Interpretation Concerns Regarding the Emulated Target Trial of SGLT2 Inhibitors vs GLP-1 Receptor Agonists in Psoriatic Arthritis [Letter].
Journal: Drug design, development and therapy
Published: August 08, 2026
Evaluating Zasocitinib as an oral therapy for moderate to severe plaque Psoriasis.
Journal: Expert opinion on pharmacotherapy
Published: August 05, 2026
Last Updated: 09/26/2026